Trinity Capital Inc. (NASDAQ:TRIN – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday after the company announced better than expected quarterly earnings. The ...
Q4 2024 Earnings Conference Call February 26, 2025 12:00 PM ETCompany ParticipantsBen Malcolmson - Head, IRKyle Brown ...
Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the stock. Trinity Biotech Price ...
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...
Hosted on MSN21d
Trinity Biotech’s CGM System Shows Breakthrough ImprovementsTrinity Biotech ( (TRIB)) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous glucose monitoring (CGM) system, following its latest pre ...
(RTTNews) - Trinity Biotech plc (TRIB), a biotechnology company focused on diabetes management, on Thursday announced notable advances in its pre-pivotal trial for its next-generation continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results